John Kramer
Overview
Explore the profile of John Kramer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
3489
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gentles A, Wong S, Orr N, Noga H, Allaire C, Williams C, et al.
J Pain
. 2025 Mar;
:105357.
PMID: 40049377
There is increasing recognition that nociplastic pain and central sensitization may play a role in endometriosis-associated pain. The Pain Sensitivity Questionnaire Minor (PSQ-M) evaluates subjective widespread pain sensitivity, and is...
2.
Toubasi A, Eisma J, Wang J, Kazimuddin H, Hernandez B, Vinarsky T, et al.
Ann Clin Transl Neurol
. 2024 Oct;
11(11):2912-2922.
PMID: 39447194
Objective: Paramagnetic rim lesions (PRLs) are a biomarker of chronic active lesions (CALs), and an important driver of neurological disability in multiple sclerosis (MS). The reason subtending some acute lesions...
3.
Todd K, Kramer J, Olsen K, Martin Ginis K
BMJ Open Sport Exerc Med
. 2024 Aug;
10(3):e001828.
PMID: 39104373
Background: Chronic pain among athletes is often misinterpreted as tissue damage resulting from sport. While researchers have started to examine neuropathic pain among athletes with spinal cord injury (SCI), there...
4.
Li J, Farrow M, Ibrahim K, McTigue D, Kramer J, Tong B, et al.
Spinal Cord
. 2024 Jul;
62(8):486-494.
PMID: 38961159
Study Design: Secondary analysis of a randomized, multi-center, placebo-controlled study(Sygen®). Objectives: To evaluate racial differences in serological markers in individuals with spinal cord injury(SCI) across the first year of injury....
5.
Schneider M, Kramer J, Banks A, Moses H
Mult Scler
. 2024 Apr;
30(10):1379-1382.
PMID: 38605496
Lymphopenia is a known adverse effect in patients with relapsing multiple sclerosis (RMS) treated with fumaric acids. We present a case series of four patients diagnosed with RMS with prolonged...
6.
Barr P, Neale Z, Chatzinakos C, Schulman J, Mullins N, Zhang J, et al.
Res Sq
. 2024 Feb;
PMID: 38405959
Research has identified clinical, genomic, and neurophysiological markers associated with suicide attempts (SA) among individuals with psychiatric illness. However, there is limited research among those with an alcohol use disorder...
7.
Colbert S, Mullins N, Chan G, Meyers J, Schulman J, Kuperman S, et al.
Complex Psychiatry
. 2023 Dec;
9(1-4):11-23.
PMID: 38058956
Introduction: Suicidal thoughts and behaviors have partially distinct genetic etiologies. Methods: We used PRS-CS to create polygenic risk scores (PRSs) from GWAS of non-suicidal self-injury, broad-sense self-harm ideation, nonfatal suicide...
8.
Kwon S, Bhurawala H, Munoz A, Kramer J, Poulton A
Australas Psychiatry
. 2023 Nov;
32(1):18-22.
PMID: 37936255
Objective: The Review of health services for children, young people and families within the NSW Health system identified that novel models of care were needed to improve access to clinical...
9.
Kramer J, Linker R, Paling D, Czaplinski A, Hoffmann O, Yong V, et al.
Mult Scler J Exp Transl Clin
. 2023 Oct;
9(4):20552173231203816.
PMID: 37829441
Background: Ofatumumab is approved for treating relapsing multiple sclerosis (RMS). Examining tolerability will enable understanding of its risk-benefit profile. Objective: Report the tolerability profile of ofatumumab in RMS during treatment...
10.
Miller A, Kuo S, Johnson E, Tillman R, Brislin S, Dick D, et al.
JAMA Netw Open
. 2023 Oct;
6(10):e2337192.
PMID: 37815828
Importance: Current Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) (DSM-5) diagnoses of substance use disorders rely on criterion count-based approaches, disregarding severity grading indexed by individual criteria. Objective:...